Spartanburg, South Carolina 29303


Purpose:

The objective of this study is to evaluate the microbial consortia and the host inflammatory factors present in the nasal passages of patients during upper respiratory symptomology and when healthy using culture and molecular analysis techniques.


Criteria:

Inclusion Criteria: - Adults, male or female, between the ages 18 - 60 - Exhibiting symptoms of an upper respiratory ailment, which may include runny or stuffy nose, sore throat, fever, headache, cough, malaise, or loss of appetite with no indication or intention to treat with excluded medications. Exclusion Criteria: - Use of antibiotics, antifungals, antivirals, antihistamines, anticholinergic, anti-inflammatory, any nasal inhaled medications (other than saline), or steroid medications within the four (4) weeks prior to enrollment and during the course of the study. Use of cough suppressants and herbal medications are permitted.


NCT ID:

NCT02535442


Primary Contact:

Principal Investigator
Charles Fogarty, MD
Spartanburg Medical Research

Jami Jones
Phone: (864) 583-1556
Email: jjones@medresearch.com


Backup Contact:

N/A


Location Contact:

Spartanburg, South Carolina 29303
United States

Jami Jones
Phone: 864-237-8517

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.